GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medipal Holdings Corp (TSE:7459) » Definitions » EPS without NRI

Medipal Holdings (TSE:7459) EPS without NRI : 円163.57 (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Medipal Holdings EPS without NRI?

Medipal Holdings's earnings per share without non-recurring items for the three months ended in Dec. 2023 was 円53.35. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was 円163.57.

During the past 12 months, Medipal Holdings's average earnings per share (NRI) Growth Rate was 0.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 11.60% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 3.30% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 3.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Medipal Holdings's EPS without NRI or its related term are showing as below:

TSE:7459' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -29.5   Med: 2.4   Max: 26.4
Current: 11.6

During the past 13 years, Medipal Holdings's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 26.40% per year. The lowest was -29.50% per year. And the median was 2.40% per year.

TSE:7459's 3-Year EPS without NRI Growth Rate is not ranked
in the Medical Distribution industry.
Industry Median: 5 vs TSE:7459: 11.60

Medipal Holdings's EPS (Diluted) for the three months ended in Dec. 2023 was 円52.71. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円195.83.

Medipal Holdings's EPS (Basic) for the three months ended in Dec. 2023 was 円52.71. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円195.83.


Medipal Holdings EPS without NRI Historical Data

The historical data trend for Medipal Holdings's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipal Holdings EPS without NRI Chart

Medipal Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.14 118.16 145.97 163.40 164.44

Medipal Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.90 41.58 28.15 53.35 40.49

Competitive Comparison of Medipal Holdings's EPS without NRI

For the Medical Distribution subindustry, Medipal Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medipal Holdings's PE Ratio without NRI Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's PE Ratio without NRI falls into.



Medipal Holdings EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円163.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medipal Holdings  (TSE:7459) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Medipal Holdings EPS without NRI Related Terms

Thank you for viewing the detailed overview of Medipal Holdings's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Medipal Holdings (TSE:7459) Business Description

Traded in Other Exchanges
Address
2-7-15, Yaesu, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp distributes pharmaceuticals and health and beauty products to medical institutions and retailers. The firm operates in three segments: prescription pharmaceutical wholesale; cosmetics, daily necessities, and OTC pharmaceutical wholesale; and animal health products wholesale. The prescription pharmaceutical business generates the majority of revenue and distributes products to hospitals, clinics, and pharmacies. The cosmetics, daily necessities, and OTC pharmaceutical businesses distribute products to drugstores, convenience stores, and supermarkets. The animal health segment conducts wholesale business for animal hospitals, farms, and agricultural cooperatives. Medipal Holdings generates the vast majority of its revenue in Japan.

Medipal Holdings (TSE:7459) Headlines

No Headlines